Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -15.93M | -17.44M | -14.14M | -9.54M | |
| Total Depreciation and Amortization | 212.00K | 208.00K | 148.00K | 151.00K | |
| Total Amortization of Deferred Charges | -- | 14.00K | 1.00K | -- | |
| Total Other Non-Cash Items | 2.75M | 2.71M | 1.81M | 107.00K | |
| Change in Net Operating Assets | -1.04M | -8.84M | 5.70M | -1.35M | |
| Cash from Operations | -14.01M | -23.35M | -6.47M | -10.63M | |
| Capital Expenditure | -18.00K | -15.00K | -10.00K | -9.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 15.93M | -- | -- | |
| Cash from Investing | -18.00K | 15.91M | -10.00K | -9.00K | |
| Total Debt Issued | -- | 0.00 | 6.00M | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 58.88M | 10.00K | 10.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -77.00K | 51.36M | -142.00K | -- | |
| Cash from Financing | -77.00K | 110.25M | 5.87M | 10.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -14.10M | 102.80M | -615.00K | -10.63M | |